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ABSTRACT 
Transitional mucosa of the colon is the tissue immediately adjacent to 
a cancer, which has histochemical and ultrastructural features similar 
to those seen in neoplasia. Therefore, it has been hypothesized in 
the past that this tissue represents the premalignant antecedent to 
colonic adenocarcinoma. Other investigators have disputed this explan- 
ation because similar changes are found adjacent to colonic lesions 
other than adenocarcinoma. 
The hypothesis offered here suggests that transitional mucosa may 
result from the paracrine influence of tumor growth factors released 
by the tumor. Candidate peptide hormones known to be produced by 
tumors are proposed, and a framework is outlined to explain the 
occurrence of transitional mucosa adjacent to non-neoplastic lesions. 
Transitional mucosa may be both a genuine reflection of the 
transformed phenotype and yet a "reactive" phenomenon secondary to the 
presence of the adjacent tumor. 
TRANSITIONAL MUCOSA AND COLONIC NEOPLASIA ~- 
Transitional mucosa in the colon is epithelium immediately adjacent to 
a cancer, usually confined to a zone no larger than 2 cm from the 
morphological border of the tumor. In 1969, it was first reported by 
Filipe that this mucosa has abnormal histochemical properties (1.2). 
Although there was a sharp change in the pathological appearance 
between the cancer and non-malignant mucosa, a decrease in the 
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normally expressed sulfomucins accompanied by a replacement with 
sialomucins was noted in this tissue. Since neoplastic colonic 
lesions contained a heterogeneous mixture of neutral and other non- 
sulfated mucins compared with the predominantly sulfated mucins in 
normal colonic mvcosa, Filipe suggested that transitional mucosa was 
epithelium at an early stage in carcinogenesis (2). 
In 1977, Saffos and Rhatigan (3) examined transitional mucosa in 
detail' using light microscopy and reported an increase in the length 
of crypts, frequent distention and branching of the crypts, and an 
increase in the number of goblet cells per crypt. However, 
cytological atypia was not observed and mitotic activity remained 
confined to the bottom half of the crypt. When these changes were 
sought in randomly located specimens of grossly normal colon distant 
from the cancers, significant deviations from the normal histological 
pattern were seen in only 1 of 20, leading to the conclusion that 
these changes were generally confined to the rim around the tumor. 
The ultrastructural characteristics of transitional mucosa were 
described by Dawson and Filipe in 1976 (41, and Riddell and Levin in 
1977 (5). They reported an increase in the numbers of mature goblet 
cells in the lower half of the crypt and an increase in immature 
goblet cells and "intermediate cells" in the upper half of the crypts. 
The crypts were shown to be larger in diameter and composed of larger 
cells with larger nuclei than seen in normal colon. Similar changes 
were described adjacent to a sessile cecal adenoma that was free of 
cancer. 
Therefore, the epithelium appeared to be under the influence of a 
substance (or substances) that stimulates cell growth and 
proliferation. This was consistent with the hypothesis that 
transitional mucosa might be premalignant, although the investigators 
admitted that it was not possible to conclude whether these were early 
neoplastic changes or nonspecific reactive phenomena. 
Other groups have subsequently described additional changes in the 
mucin of transitional mucosa such as the appearance of the fetal-type 
M-l antigen (6,7). A unique type of carbohydrate structure, that 
which binds peanut lectin, was found in the mucins of carcinoma as 
well as transitional mucosa, but not normal colon (8,9). This 
observation has been confirmed usin polyclonal and monoclonal 
antibodies to the structure recognized by peanut lectin, the T 
(Thomsen-Friedenreich) antigen (10). 
Meanwhile, other laboratories have demonstrated that the morphological 
or histochemical changes seen in transitional mucosa may be seen 
adjacent to squamous cell carcinoma of the anus (11,121, a variety of 
sarcomas in the colon (12,13), endometriosis (13.15) and colonic 
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inflammation due to diverticulosis and ischemic necrosis (15). These 
observations have suggested that the morphological and 
histochemical changes in this mucosa may be reactive rather t.han a 
primary premalignant lesion. 
HYPOTHESIS 
How can these differing explanations be resolved? In part, both may 
be correct. Transitional mucosa may be a genuine reflection of the 
neoplastic phenotype, but one which may occur secondary to the 
paracrine influence of tumor growth factors released by the tumor. 
Fig. 1. Schematic representation of transitional mucosa. E= 
epithelium, S = submucosa, M = Muscularis propria, TM = transitional 
mucosa, TGF = tumor growth factors. 
What evidence may be brought to bear on this hypothesis? First, Filipe 
reported that the width of the zone of transitional mucosa was related 
to the size of the tumor, e.g., 1.3 cm in staqe A tumors, 2.7 cm in 
stage B tumors, and 3.5 cm in stage C tumors(2). If transitional 
mucosa were the premaliqnant antecedent to cancer, one might expect to 
find diffuse changes throughout the colon, and the focal changes that 
preceded a neoplastic lesion would tend to be overgrown by an 
expanding tumor. In this case, the size of the zone of transitional 
mucosa would be inversely related to the size of associated tumor, and 
foci might be found around adenomas and in flat mucosa, which is not 
commonly the case. An alternative explanation is that "growth 
factors" produced in the tumor may be released into the interstitial 
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fluid and diffuse into adjacent tissues, producinq the changes seen in 
transitional mucosa (Fig. 1). 
What evidence is there for the existence of diffusible qrowth factors 
in tumors? Cancer cells from solid tumors may produce a variety of 
peptide hormones capable of producing a reversible neoplastic 
phenotype in non-transformed cells (16-18). These peptides are 
released from cultured tumor cells into the culture medium, and are 
theoretically capable of stimulating proliferation and phenotypic 
changes in adjacent normal tissue by a paracrine mechanism (19). 
Two candidate peptides known to be produced by tumor cells are 
epidermal growth factor (EGF) (20) and platelet derived growth 
factor (21). Chemical transformation of anchorage-dependent (i.e., 
non-malignant) cells results in the production of a low molecular 
weight peptide that interacts with the EGF receptor and promotes the 
growth of previously anchorage-dependent cells in soft agar. In 
short, the peptide confers the malignant phenotype to non-transformed 
cells (22). 
A low molecular weight peptide that promotes mitogenesis may therefore 
be produced by and released from tumor cells, where it may serve an 
autocrine function. If produced in excess, this peptide may diffuse 
through the interstitial fluid and influence the adjacent colonic 
epithelium (i.e., as a paracrine effect). Under the influence of a 
tumor growth factor, the "transitional epithelium" would be (perhaps 
reversibly) stimulated to hypertrophy and proliferate. The mechanism 
by which proliferation is stimulated is not entirely clear, however, 
it has been observed that EGF binds to a membrane receptor, activates 
a tyrosine kinase (20,231, and stimulates ornithine decarboxylase 
activity (24). The amino acid sequences of platelet derived growth 
factor are highly homologous with the gene product of the simian 
sarcoma virus (20,25,26). In addition, the C-sis oncoqene directs the 
synthesis of a functional platelet-derived growth factor subunit, and 
several other oncogenes appear to encode for functional components of 
the qrowth-requlatinq cascade (27). 
The zone of transitional mucosa might be a variable function of the 
relative amounts of tumor growth factors produced by the cancer, both 
in terms of the intrinsic ability of the tumor to synthesize these 
peptides per unit of tumor mass, and the total size of the tumor. 
Thus, it would not be likely to find isolated nests of "transitional 
mucosa" distant from tumors, and the size of the zone of 
ultrastructurally and histochemically abnormal epithelium would be 
related to the ability of the tumors to generate and release these 
substances. This would explain the presence of transitional mucosa 
adjacent to metastatic tumors and other non-carcinomatous malignancies 
in the colon, since the presence of transitional mucosa would be a 
function of the ability of any tumor to release growth factors. It is 
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tempting to speculate that some of the epithelial changes adjacent to 
large cancers, which have been classically interpreted as residual 
tissue from a preexisting adenoma, may actually represent previously 
normal colonic tissue under the influence of stimulation by a tumor 
growth factor. 
It still remains to be explained why the histochemical properties of 
transitional mucosa are seen adjacent to non-neoplastic disease such 
as the solitary rectal ulcer or in an inflamed colon. Tissue injury 
is followed by cellular proliferation and repair, and this may require 
the activation of cellular genes that produce changes in morphology 
and glycoprotein biosynthesis that mimic those seen in neoplasia. This 
process may be mediated in part by platelet derived growth factor , 
as platelets are sequestered in the usual inflammatory response (21). 
Again, there is a similarity between the actions of this peptide 
hormone and the gene product of a well characterized oncogene (21). 
The difference between repair and neoplasia lies in the autonomy of 
proliferation achieved in cancer. The difficulty in morphologically 
distinguishing brisk repair from early neoplasia is known to every 
lz4thologist. The explanation may be that both processes share common 
Ielztide hormones that stimulate changes in the biology of the 
epithelial cell critical for repair on the one hand (when regulated) 
and characteristic of neoplasia on the other (when out of control!. 
CONCLUSICN 
Thus, authors on both side of the issue may be correct concerning 
transitional mucosa. This tissue may appear fundamentally neoplastic 
in nature because of the paracrine influence of tumor growth factors 
produced by the adjacent tumor. The tissue is not premalignant under 
this conceptual framework, since it would not antedate the tumor, and 
the transformation may be reversible. This would account for the 
observation that "transitional mucosa-like" colonic epithelium may be 
found adjacent to other malignancies by virtue of the release of tumor 
growth factors, and non-neoplastic colonic diseases by virtue of the 
appearance of platelet derived growth factor involved in the response 
to injury and repair. 
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